JTCS St. Jude Medical
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ralph A. Schmid
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frese, S.
Right arrow Articles by Schmid, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frese, S.
Right arrow Articles by Schmid, R. A.
Related Collections
Right arrow Molecular biology

J Thorac Cardiovasc Surg 2003;126:748-754
© 2003 The American Association for Thoracic Surgery


General thoracic surgery

Cell death induced by down-regulation of heat shock protein 70 in lung cancer cell lines is p53-independent and does not require DNA cleavage

Steffen Frese, MDa,*, Manuela Schaper, BSca, Jan-Rasmus Kuster, MDa, Daniela Mieschera, Marja Jäättelä, MD, PhDb, Thomas Buehler, PhDc, Ralph A. Schmid, MDa

a From the Division of General Thoracic Surgery, University Hospital, Berne, Switzerland
b Apoptosis Laboratory, Danish Cancer Society, Copenhagen, Denmark
c Novartis, Basel, Switzerland

Received for publication November 1, 2001; accepted for publication January 21, 2003.

* Address for reprints: Steffen Frese, MD, Department of Clinical Research, Murtenstrasse 35 Room C807, CH-3010, Berne, Switzerland
steffen.frese{at}web.de

OBJECTIVE: The inducible form of heat shock protein 70 is known to be overexpressed in tumors and seems to be necessary for the survival of tumor cells via an unknown mechanism. We therefore evaluated whether selective depletion of heat shock protein 70 induces cell death in lung cancer cells.

METHODS: An adenovirus expressing antisense heat shock protein 70 and an adenovirus with ß-galactosidase were used for transduction of the lung cancer cell lines A549, NCI-H358, LXF-289, LOU-NH91, normal human bronchial epithelial cells, and normal lung fibroblasts IMR90. Cell death was determined by morphology, propidium iodide uptake, and trypan blue staining; DNA cleavage was assessed by terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling. Expression of heat shock protein 70, heat shock cognate 70, and phosphorylated p53 was determined by Western blot analysis.

RESULTS: Transduction of lung cancer cells with adenovirus expressing antisense heat shock protein 70 but not with adenovirus with ß-galactosidase resulted in extensive cell death after 96 hours (A549: 53.2 ± 9.44% versus 12.9 ± 6.6%; NCI-H358: 48.4 ± 7.2% versus 25.2 ± 1.4%; LXF-289: 58.8 ± 6.5% versus 24.7 ± 5.4%; LOU-NH91: 82.5 ± 1.8% versus 38.5 ± 2.6%). In contrast, adenovirus expressing antisense heat shock protein 70 showed much less cytotoxicity in normal human bronchial epithelial cells (16.0 ± 0.5% versus 17.1 ± 7.3%) and in normal lung fibroblasts IMR90 (17.2 ± 3.6% versus 8.2 ± 1.6%). After treatment with adenovirus expressing antisense heat shock protein 70, transactivation of p53 in A549 but not in NCI-H358, a cell line deleted for p53 has been observed. Furthermore, 22.0 ± 3.0% of A549 cells treated for adenovirus expressing antisense heat shock protein 70 stained positive with terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling versus 10.2 ± 4.0% treated with control virus. This effect but not cell death itself was blocked by treatment with 10 µmol/L zVAD-fmk, a broad caspase inhibitor.

CONCLUSIONS: Selective down-regulation of heat shock protein 70 induces cell death in lung cancer but not in normal lung cells. The demonstrated effect is p53-independent and does not require DNA cleavage. The data suggest that gene transfer of antisense heat shock protein 70 might be useful in developing new strategies for the treatment of lung cancer.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The American Association for Thoracic Surgery.